Abstract

Objective. To evaluate risk factors which influence sputum smear conversion, outcome, and trends of conversion of sputum smear during 5 years and compare outcomes in patients with different regimens. Methods. In a retrospective cohort study, all patients with sputum smear positive tuberculosis were evaluated for comorbidities and demographic, microbiological, and therapeutic data and outcome. Smear examinations were performed at the beginning, at 2 months for CAT I, at 3 months for CAT II, at the end of second month of maintenance phase, and at the end of treatment. Results. This study enrolled 211 sputum smear positive patients, but 189 patients who completed the intensive phase of treatment were evaluated. Sputum smear of 158 patients converted at the end of intensive phase (83.6). Univariate analysis indicated that the risk of a persistent positive smear at the end of intensive phase was greater in diabetic patients ((odds 4.038, 95% CI 1.123–14.516) P = 0.033), and also a 3+bacillary load had risk of 2.933-fold ((95% CI 1.278–6.732) P = 0.011). Overall rate of unfavorable outcome was 20.9%. Factors associated with unfavorable outcome were age (P value 0.000), male gender (P value 0.027), diabetes (P value 0.000), and delayed conversion of sputum at the end of intensive phase (P value 0.000). Outcome for different regimens was not different significantly. Two specimens were isoniazid resistant. Conclusions. We suggest supervised treatment and care for diabetic patients and those with higher bacillary load. Paying attention to early diagnosis of tuberculosis in the elderly to reduce poor outcome and further measures to prevent transfer-out could improve the success rate.

Highlights

  • Tuberculosis (TB) remains a global health problem

  • Of 211 patients who were enrolled into the study, 22 had no record of sputum conversion at the end of the intensive phase; reasons were as follows: 9 patients were transferred out and 13 patients deceased during intensive phase of treatment

  • Of 189 patients who completed the intensive phase of treatment, sputum smear of one hundred and fifty-eight patients converted at the end of intensive phase (83.6%)

Read more

Summary

Introduction

Tuberculosis (TB) remains a global health problem. In 2011, there were an estimated 8.7 million new cases of TB (13% coinfected with HIV) and 1.4 million people died from TB. Sputum smear conversion at the end of the intensive phase of treatment is used as an important early predictor of treatment success [2,3,4]. The sputum conversion results are used both for management of patients and for monitoring programmed performance [5]. Several studies evaluated risk factors such as age, smear grading, gender, influence of directly observed therapy (DOT), and associated comorbid conditions like HIV infection and diabetes mellitus among tuberculosis patients [5,6,7,8]. In recent years Tuberculosis Trials Consortium Study 28 found later sputum culture conversion and lower rates of conversion in liquid media in African patients compared to non-African patients [10]. We studied risk factors which influence smear conversion and evaluated

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call